Company News from the 04/07/06 News Brief

Share this article:
Pfizer has entered into an agreement to acquire Rinat Neuroscience, a privately held biotechnology company that is developing therapeutic proteins for the treatment of diseases and disorders of the central nervous system. Financial terms of the deal were not disclosed. Rinat’s lead product has just started Phase II trials as a treatment for osteoarthritis pain.
Share this article:
You must be a registered member of MMM to post a comment.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.